메뉴 건너뛰기




Volumn 66, Issue 1, 2009, Pages 38-44

Development of computerized alerts with management strategies for 25 serious drug-drug interactions

Author keywords

Ambulatory care; Computers; Drug interactions; Quality assurance

Indexed keywords

ACETYLSALICYLIC ACID; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CLARITHROMYCIN; CODEINE; DIHYDROERGOTAMINE; ERGOT ALKALOID; ERGOTAMINE; ERYTHROMYCIN; ESTAZOLAM; FLUCONAZOLE; FROVATRIPTAN; ITRACONAZOLE; LORAZEPAM; MACROLIDE; MIDAZOLAM; OXAZEPAM; PARACETAMOL; POSACONAZOLE; PYRROLE DERIVATIVE; QUAZEPAM; RIZATRIPTAN; SEROTONIN DERIVATIVE; SUMATRIPTAN; TRIAZOLAM; TRIPTAN DERIVATIVE; TROLEANDOMYCIN; UNINDEXED DRUG; VORICONAZOLE; ZOLMITRIPTAN;

EID: 62449276097     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070046     Document Type: Article
Times cited : (10)

References (24)
  • 1
    • 0036884965 scopus 로고    scopus 로고
    • Improving recognition of drug interactions: Benefits and barriers to using automated drug alerts
    • Glassman PA, Simon B, Belperio P et al. Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med Care. 2002; 40:1161-1171
    • (2002) Med Care , vol.40 , pp. 1161-1171
    • Glassman, P.A.1    Simon, B.2    Belperio, P.3
  • 2
    • 0035290303 scopus 로고    scopus 로고
    • Preventable medication errors: Identifying and eliminating serious drug interactions
    • Peterson JF, Bates DW. Preventable medication errors: identifying and eliminating serious drug interactions. J Am Pharm Assoc. 2001; 41:159-160
    • (2001) J Am Pharm Assoc , vol.41 , pp. 159-160
    • Peterson, J.F.1    Bates, D.W.2
  • 4
    • 0002516933 scopus 로고    scopus 로고
    • Evaluation of online prospective DUR programs in community pharmacy practice
    • Chui MA, Rupp MT. Evaluation of online prospective DUR programs in community pharmacy practice. J Manag Care Pharm. 2000; 6:27-32.
    • (2000) J Manag Care Pharm , vol.6 , pp. 27-32
    • Chui, M.A.1    Rupp, M.T.2
  • 5
    • 12544252476 scopus 로고    scopus 로고
    • Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice
    • Chen YF, Avery AJ, Neil KE et al. Incidence and possible causes of prescribing potentially hazardous/contraindicated drug combinations in general practice. Drug Saf. 2005; 28:67-80.
    • (2005) Drug Saf , vol.28 , pp. 67-80
    • Chen, Y.F.1    Avery, A.J.2    Neil, K.E.3
  • 7
    • 0032011668 scopus 로고    scopus 로고
    • How pharmacists respond to on-line, real-time DUR alerts
    • Armstrong EP, Denemark CR. How pharmacists respond to on-line, real-time DUR alerts. J Am Pharm Assoc. 1998; 38:149-154
    • (1998) J Am Pharm Assoc , vol.38 , pp. 149-154
    • Armstrong, E.P.1    Denemark, C.R.2
  • 8
    • 0031138096 scopus 로고    scopus 로고
    • On-line DUR messages: Pharmacists' attitudes and actions in response
    • Armstrong EP, Markson TJ. On-line DUR messages: pharmacists' attitudes and actions in response. J Am Pharm Assoc. 1997; NS37:315-320
    • (1997) J Am Pharm Assoc , vol.NS37 , pp. 315-320
    • Armstrong, E.P.1    Markson, T.J.2
  • 9
    • 0036404781 scopus 로고    scopus 로고
    • GPs' views on computerized drug interaction alerts: Questionnaire survey
    • DOI 10.1046/j.1365-2710.2002.00434.x
    • Magnus D, Rodgers S, Avery AJ. GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther. 2002; 27:377-382 (Pubitemid 35286237)
    • (2002) Journal of Clinical Pharmacy and Therapeutics , vol.27 , Issue.5 , pp. 377-382
    • Magnus, D.1    Rodgers, S.2    Avery, A.J.3
  • 10
    • 0033844234 scopus 로고    scopus 로고
    • Disagreement among drug compendia on inclusion and ratings of drug-drug interactions
    • Fulda TR, Baluck RJ, Vander Zanden J et al. Disagreement among drug compendia on inclusion and ratings of drug-drug interactions. Curr Ther Res. 2000; 61:540-548
    • (2000) Curr Ther Res , vol.61 , pp. 540-548
    • Fulda, T.R.1    Baluck, R.J.2    Vander Zanden, J.3
  • 11
    • 3042701845 scopus 로고    scopus 로고
    • Concordance of severity ratings provided in four drug interaction compendia
    • Abarca J, Malone DC, Armstrong EP et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc. 2004; 44:136-141
    • (2004) J Am Pharm Assoc , vol.44 , pp. 136-141
    • Abarca, J.1    Malone, D.C.2    Armstrong, E.P.3
  • 12
    • 0035292729 scopus 로고    scopus 로고
    • Performance of community pharmacy drug interaction software
    • Hazlet TK, Lee TA, Hansten PD et al. Performance of community pharmacy drug interaction software. J Am Pharm Assoc. 2001; 41:200-204
    • (2001) J Am Pharm Assoc , vol.41 , pp. 200-204
    • Hazlet, T.K.1    Lee, T.A.2    Hansten, P.D.3
  • 18
    • 0004127828 scopus 로고    scopus 로고
    • St. Louis: Facts and Comparisons, Inc.
    • Tatro DS. Drug interaction facts. St. Louis: Facts and Comparisons, Inc.; 2001.
    • (2001) Drug Interaction Facts
    • Tatro, D.S.1
  • 22
    • 0003845629 scopus 로고    scopus 로고
    • Bethesda, MD: American Society of Health-System Pharmacists
    • AHFS drug information 2007. Bethesda, MD: American Society of Health-System Pharmacists; 2007.
    • (2007) AHFS Drug Information 2007
  • 23
    • 3042658496 scopus 로고    scopus 로고
    • Drug interactions in primary care: Impact of a new algorithm on risk determination
    • Bergk V, Gasse C, Rothenbacher D et al. Drug interactions in primary care: impact of a new algorithm on risk determination. Clin Pharmacol Ther. 2004; 76:85-96.
    • (2004) Clin Pharmacol Ther , vol.76 , pp. 85-96
    • Bergk, V.1    Gasse, C.2    Rothenbacher, D.3
  • 24
    • 8744267127 scopus 로고    scopus 로고
    • Requirements for a successful implementation of drug interaction information systems in general practice: Results of a questionnaire survey in Germany
    • DOI 10.1007/s00228-004-0812-6
    • Bergk V, Gasse C, Schnell R et al. Requirements for a successful implementation of drug interaction information systems in general practice: results of a questionnaire survey in Germany. Eur J Clin Pharmacol 2004; 60:595-602. (Pubitemid 39517914)
    • (2004) European Journal of Clinical Pharmacology , vol.60 , Issue.8 , pp. 595-602
    • Bergk, V.1    Gasse, C.2    Schnell, R.3    Haefeli, W.E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.